These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 22217953)

  • 1. Parkinsonism and rabbit syndrome after discontinuation of low-dose ziprasidone and concomitant initiation of sertraline.
    Gray JA
    J Clin Psychopharmacol; 2012 Feb; 32(1):142-3. PubMed ID: 22217953
    [No Abstract]   [Full Text] [Related]  

  • 2. Paliperidone-related rabbit syndrome.
    Teng PR; Lai TJ
    J Clin Psychopharmacol; 2011 Jun; 31(3):379-80. PubMed ID: 21532365
    [No Abstract]   [Full Text] [Related]  

  • 3. Rabbit syndrome following discontinuation of paliperidone in a patient with schizoaffective disorder.
    Liang CS; Yang FW; Huang YC
    J Clin Psychopharmacol; 2012 Oct; 32(5):720-1. PubMed ID: 22926613
    [No Abstract]   [Full Text] [Related]  

  • 4. Paliperidone-related Pisa syndrome.
    Teng PR; Lai TJ
    J Clin Psychopharmacol; 2013 Feb; 33(1):129-31. PubMed ID: 23288235
    [No Abstract]   [Full Text] [Related]  

  • 5. Early-onset tardive dyskinesia in a neuroleptic-naive patient exposed to paliperidone.
    Hsu WY; Chiu NY
    J Clin Psychopharmacol; 2013 Oct; 33(5):712-3. PubMed ID: 23899637
    [No Abstract]   [Full Text] [Related]  

  • 6. Pisa syndrome induced by paliperidone.
    Pan PY; Chou HW; Cheng CC; Hsu YC; Tzeng NS
    J Neuropsychiatry Clin Neurosci; 2014; 26(1):E07-8. PubMed ID: 24515688
    [No Abstract]   [Full Text] [Related]  

  • 7. Tardive Tourette-like syndrome in a patient treated with paliperidone.
    Fountoulakis KN; Panagiotidis P
    J Neuropsychiatry Clin Neurosci; 2011; 23(4):E35-6. PubMed ID: 22231343
    [No Abstract]   [Full Text] [Related]  

  • 8. Oral-paliperidone-induced tardive dyskinesia: a case report.
    Wei HT; Lai YW; Chen MH; Chen YS
    Gen Hosp Psychiatry; 2012; 34(5):578.e5-6. PubMed ID: 22154659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paliperidone-induced neuroleptic malignant syndrome.
    Nayak RB; Bhogale GS; Patil NM; Chate SS; Pandurangi AA; Shetageri VN
    J Neuropsychiatry Clin Neurosci; 2011; 23(1):E14-5. PubMed ID: 21304113
    [No Abstract]   [Full Text] [Related]  

  • 10. Paliperidone-associated atypical neuroleptic malignant syndrome: a case report.
    Han C; Lee SJ; Pae CU
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):650-1. PubMed ID: 21163319
    [No Abstract]   [Full Text] [Related]  

  • 11. Possible paliperidone-induced neuroleptic malignant syndrome: a case report.
    Özdemir A; Aksoy-Poyraz C; Kılıç-Yener E
    J Neuropsychiatry Clin Neurosci; 2012; 24(3):E22-3. PubMed ID: 23037666
    [No Abstract]   [Full Text] [Related]  

  • 12. Paliperidone-induced mania-like symptoms: a case report.
    Wang WT; Chen CH; Lu ML; Lai TJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Oct; 34(7):1351-2. PubMed ID: 20600461
    [No Abstract]   [Full Text] [Related]  

  • 13. Paliperidone overdose in a patient with schizophrenia.
    Chang JP; Huang CC; Su KP
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):418. PubMed ID: 19995588
    [No Abstract]   [Full Text] [Related]  

  • 14. Paliperidone-induced tardive dystonia: a case report.
    Havaki-Kontaxaki B; Karaiskos D; Pappa D; Papadimitriou GN
    J Neuropsychiatry Clin Neurosci; 2013; 25(2):E51. PubMed ID: 23686064
    [No Abstract]   [Full Text] [Related]  

  • 15. Emergence of neuroleptic malignant syndrome while switching between risperidone and paliperidone.
    Teng PR; Lane HY
    J Neuropsychiatry Clin Neurosci; 2011; 23(4):E16-7. PubMed ID: 22231327
    [No Abstract]   [Full Text] [Related]  

  • 16. Paliperidone-induced leukopenia and neutropenia: a case report.
    Kim JN; Lee BC; Choi IG; Jon DI; Jung MH
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jan; 35(1):284-5. PubMed ID: 20920543
    [No Abstract]   [Full Text] [Related]  

  • 17. Paliperidone-induced obsessive symptoms.
    Paparrigopoulos T; Tzavellas E; Karaiskos D; Liappas I
    J Neuropsychiatry Clin Neurosci; 2011; 23(2):E46. PubMed ID: 21677227
    [No Abstract]   [Full Text] [Related]  

  • 18. Possible neuroleptic malignant syndrome during paliperidone administration: a case report.
    Mantas C; Kalabokis G; Goulia P; Tourlakopoulos A; Hyphantis T; Mavreas V
    J Clin Psychopharmacol; 2010 Feb; 30(1):89-91. PubMed ID: 20075663
    [No Abstract]   [Full Text] [Related]  

  • 19. Risperidone/paliperidone induced neutropenia and lymphopenia.
    Raj V; Druitt T; Purushothaman S; Dunsdon J
    Aust N Z J Psychiatry; 2013 Mar; 47(3):291-2. PubMed ID: 22984110
    [No Abstract]   [Full Text] [Related]  

  • 20. Prolongation of cardiac ventricular repolarization under paliperidone: how and how much?
    Hough DW; Gopal S; Coppola D; Remmerie BM; Berwaerts J; Nuamah IF; Sterkens PC; Xu Y
    J Cardiovasc Pharmacol; 2012 Mar; 59(3):298-9. PubMed ID: 22410947
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.